BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32500274)

  • 1. GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis.
    Schneider R; Kraljević M; Peterli R; Rohm TV; Klasen JM; Cavelti-Weder C; Delko T
    Obes Surg; 2020 Sep; 30(9):3561-3569. PubMed ID: 32500274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of glucagon like peptide-1 (GLP-1) on cardiac remodeling: exploring the role of medication and physiological modulation after metabolic surgery.
    Timmermans M; Topal B; Sanches EE; DE Jongh FW; Cagiltay E; Celik A; Ribeiro R; Parmar C; Ugale S; Proczko M; Stepaniak PS; Buise MP; Severin R; Pouwels S
    Minerva Endocrinol (Torino); 2022 Dec; 47(4):449-459. PubMed ID: 33759444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
    Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
    Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes.
    Ejarque M; Guerrero-Pérez F; de la Morena N; Casajoana A; Virgili N; López-Urdiales R; Maymó-Masip E; Pujol Gebelli J; Garcia Ruiz de Gordejuela A; Perez-Maraver M; Pellitero S; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Sci Rep; 2019 Apr; 9(1):6274. PubMed ID: 31000783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical insights into management options for recurrent type 2 diabetes and cardiovascular risk after metabolic-bariatric surgery.
    Lupoli R; Lembo E; Giosuè A; Schiavo L; Capaldo B
    Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1335-1342. PubMed ID: 35365370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in insulin resistance, beta cell function, glucagon-like peptide-1 and calcitonin levels two weeks after bariatric surgery.
    Sridharan K; Kalayarasan R; Kamalanathan S; Sahoo J; Kar SS; Nandhini LP; Palui R; Durgia H
    Diabetes Metab Syndr; 2019; 13(3):2142-2147. PubMed ID: 31235148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential.
    Torekov SS; Madsbad S; Holst JJ
    Obes Rev; 2011 Aug; 12(8):593-601. PubMed ID: 21401851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery.
    Iglesias P; Civantos S; Vega B; Pavón I; Guijarro G; Monereo S
    Obes Surg; 2015 Mar; 25(3):575-8. PubMed ID: 25589020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials.
    Khorgami Z; Shoar S; Saber AA; Howard CA; Danaei G; Sclabas GM
    Obes Surg; 2019 Mar; 29(3):964-974. PubMed ID: 30402804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ; De Flines J; De Roover A; Paquot N
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
    Mingrone G; Castagneto-Gissey L
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of GLP-1 in the Metabolic Success of Bariatric Surgery.
    Hutch CR; Sandoval D
    Endocrinology; 2017 Dec; 158(12):4139-4151. PubMed ID: 29040429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
    Federico A; Dallio M; Tolone S; Gravina AG; Patrone V; Romano M; Tuccillo C; Mozzillo AL; Amoroso V; Misso G; Morelli L; Docimo L; Loguercio C
    In Vivo; 2016; 30(3):321-30. PubMed ID: 27107092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.
    Magro DO; Cazzo E; Kotze PG; Vasques ACJ; Martinez CAR; Chaim EA; Geloneze B; Pareja JC; Coy CSR
    Obes Surg; 2018 Feb; 28(2):378-388. PubMed ID: 28776152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of insulin secretion by GLP-1.
    Jones B; Bloom SR; Buenaventura T; Tomas A; Rutter GA
    Peptides; 2018 Feb; 100():75-84. PubMed ID: 29412835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials.
    Rudolph A; Hilbert A
    Obes Rev; 2013 Apr; 14(4):292-302. PubMed ID: 23294936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones.
    Guerrero-Pérez F; Casajoana A; Gómez-Vaquero C; Virgili N; López-Urdiales R; Hernández-Montoliu L; Pujol-Gebelli J; Osorio J; Alves C; Perez-Maraver M; Pellitero S; Vidal-Alabró A; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2020 Jan; 30(1):180-188. PubMed ID: 31420830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.